Evidence map›Paper›PMID 34254268›Full record

ArticleJournal of racial and ethnic health disparities2022

Hispanic Ethnicity and Breast Cancer: Disaggregating Surgical Management and Mortality by Race.

Ahmad Hamad, Yaming Li, Allan Tsung, Bridget Oppong, Mariam F Eskander, Oindrila Bhattacharyya, Samilia Obeng-Gyasi

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of racial and ethnic health disparities, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ahmad HamadDivision of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, OH, USA.
Yaming LiDivision of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, OH, USA.
Allan TsungDivision of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, OH, USA.
Bridget OppongDivision of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, OH, USA.
Mariam F EskanderDivision of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, OH, USA.
Oindrila BhattacharyyaDepartment of Economics, Indiana University Purdue University, Indianapolis, IN, USA.
Samilia Obeng-GyasiDivision of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, OH, USA. samilia.obeng-gyasi@osumc.edu.ORCID 0000-0002-5330-7247
The Ohio State University · USIndiana University – Purdue University Indianapolis · US

Funding

Translational Training Grant in Experimental TherapeuticsK12CA133250 · NCI · OHIO STATE UNIVERSITY · PI WILLIAM E. CARSON, Rosa Lapalombella · 2008 to 2026
$15.0M
NCI NIH HHS K12 CA133250
6 · The paper itself

Abstract

objectiveBreast cancer is the leading cause of cancer death among Hispanic women. Unfortunately, few studies disaggregate Hispanic patients by race to understand its implications on treatment and clinical outcomes such as mortality. The aim of this study is to examine surgical management and overall mortality among different subgroups of women who self-identify as Hispanic.

methodsHispanic female patients, ages 18-90, stages I-III, diagnosed with breast cancer between 2010 and 2015 from the National Cancer Data Base were identified. The study cohort was divided into three ethnoracial categories: (1) Hispanic White (HW), 2) Hispanic Black (HB), and 3) Hispanic Other (HO). Descriptive statistics and multivariate models were constructed to determine the relationship between sociodemographic factors, clinical variables, surgical management, and mortality when disaggregated by race.

resultsThere were 56,675 Hispanic women who met the study criteria. Most where HW (n=50,599, 89.3%) and the rest were HB (n=1,334, 2.4%) and HO (n=4,742, 8.3%). There was no difference between the three groups on receipt of breast conservation therapy (P=0.12). HB (48.5%) and HO (46.6%) women were more likely to undergo reconstruction than those who identified as HW (38.7%) (P<0.001). Additionally, HB (38.3%) women were more likely to undergo tissue-based reconstruction than HW (29.0%) and HO women (30%) (P=0.0008). There was no difference between the groups in the utilization of contralateral prophylactic mastectomy (CPM) (P=0.078). On multivariable analysis, there was no difference in mortality between HB and HW patients (HR 1.18, 95%CI 0.92-1.51; Ref HW). However, HO women had a 24% relative risk reduction in mortality (HR 0.76, 95% CI 0.63-0.92; HW ref).

conclusionFindings from this study suggest there are ethnoracial disparities in reconstruction utilization and mortality among Hispanic women. Future studies should examine how culture, language, healthcare access, and patient preferences contribute to these disparities.

Indexed as

Breast NeoplasmsEthnicityAdolescentAdultAgedAged, 80 and overFemaleHealthcare DisparitiesHispanic or LatinoHumansMastectomyMiddle AgedYoung AdultBreast cancerBreast surgeryHispanicRaceReconstruction

Identifiers

PMID34254268
PMCPMC8752637
OpenAlexW3182891552

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.